Participant flow32

How many started, completed or left each group, period by period.

1 to 20 of 32

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo BID	44
Overall Study	STARTED	Fezolinetant 15 mg BID	45
Overall Study	STARTED	Fezolinetant 30 mg BID	44
Overall Study	STARTED	Fezolinetant 60 mg BID	45
Overall Study	STARTED	Fezolinetant 90 mg BID	44
Overall Study	STARTED	Fezolinetant 30 mg QD	45
Overall Study	STARTED	Fezolinetant 60 mg QD	45
Overall Study	STARTED	Fezolinetant 120 mg QD	44
Overall Study	Treated	Placebo BID	43
Overall Study	Treated	Fezolinetant 15 mg BID	45
Overall Study	Treated	Fezolinetant 30 mg BID	43
Overall Study	Treated	Fezolinetant 60 mg BID	45
Overall Study	Treated	Fezolinetant 90 mg BID	44
Overall Study	Treated	Fezolinetant 30 mg QD	43
Overall Study	Treated	Fezolinetant 60 mg QD	45
Overall Study	Treated	Fezolinetant 120 mg QD	44
Overall Study	COMPLETED	Placebo BID	37
Overall Study	COMPLETED	Fezolinetant 15 mg BID	40
Overall Study	COMPLETED	Fezolinetant 30 mg BID	38
Overall Study	COMPLETED	Fezolinetant 60 mg BID	33

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03192176/flow